Analysis Of Financing Status Quo Of China's Pharmaceutical Industry

Rational and appropriate financing is an important driving force for the survival and development of enterprises and it is also the key factor of enhancing the competitiveness of enterprises.What's more, financing is the most important guarantee for enterprises to adapt to the tide of the times and to ensure steady improvement of the economic efficiency. China's pharmaceutical industry has stepped into a relatively high-speed development period. The average growth rate of both the industrial scale and sale limit is about 10% every year. The fat profit growth not only led the large enterprises to accelerate the pace of expansion, but also continuously attract enterprises and other organizations at home and abroad involved in the field of medicine. They hope to get more medical resources and market share so that they can enhance their market competitiveness. To achieve the above goals, pharmaceutical companies are often integrated by financing. Therefore, how to finance scientifically gradually becomes the focus of pharmaceutical companies.This paper regards the financing in pharmaceutical enterprises of China as the research object. It starts with a brief introduction of the finance theory, and introduces the background, development, and practice of pharmaceutical enterprises in China. Then it thoroughly researches and analyses the actual application situation and experience of equity financing and debt financing in Chinese pharmaceutical enterprises. Study the two type financing cases of Lee's Pharmaceutical Holdings Limited and fosun medicine. And it probes into some experience and problems coming from the financing practice in Chinese pharmaceutical enterprises. And draw the conclusion that adjust the current situation about the ratio of the equity financing is greater than debt financing of our country medicine industry Finally, according to the reality of Chinese pharmacy industry, the paper puts forward some reasonable suggestions on how to finance and develop better. On the whole, people should carry out the financing activities with strategic goals and proceed from actual conditions in scientific and practical ways. And they should pay more attention to the integration after financing. In the wave of the globalization, the strength of Chinese pharmaceutical enterprises will be continuously augmented and the competitiveness of the enterprises will be improved by means of proficient and proper financing so that the enterprises can be integrated into the global competition smoothly.